You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 6, June 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psoriasis
 •Alert me on articles by topic

Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor

Daniel Creamer, MBBChir, MRCP; Michael Allen, MPhil; Rhys Jaggar, PhD; Richard Stevens, MBBS, MRCP; Roy Bicknell, DPhil; Jonathan Barker, MD

Arch Dermatol. 2002;138:791-796.

Background  Severe forms of psoriasis can be complicated by systemic microvascular hyperpermeability. Vascular endothelial growth factor (VEGF) possesses potent vascular permeability activity. We suggest that VEGF enters the systemic circulation and acts on microvessels to mediate hyperpermeability.

Objectives  To quantify renal microvascular permeability and circulating VEGF concentration in severe psoriasis, and to investigate the relationship between plasma VEGF concentration and skin and joint involvement.

Design  Inception cohort studies of patients with generalized pustular psoriasis and plaque psoriasis.

Setting  St John's Institute of Dermatology, London, England.

Patients  Twenty-two patients (15 men and 7 women) with moderate and severe psoriasis were recruited (age range, 29-77 years; mean age, 47 years); 5 had generalized pustular psoriasis, 2 had erythrodermic psoriasis, and 15 had moderate-severe plaque psoriasis. An age- and sex-matched control group of 17 individuals (10 men and 7 women) was recruited (age range, 29-69 years; mean age, 42 years).

Results  There was pathological proteinuria in patients with relapsing generalized pustular psoriasis, (4-fold increase in urinary protein excretion rate in relapse compared with remission). In patients with moderate and severe psoriasis, mean plasma VEGF concentration during relapse was approximately 2.5 times greater than during remission (mean VEGFrelapse = 257 pg/mL; mean VEGFremission = 103 pg/mL; P<.01). There was a correlation between extent of skin involvement and plasma VEGF level (mean VEGFsevere psoriasis = 365 pg/mL; mean VEGFmoderate psoriasis = 149 pg/mL; P = .03). There was a correlation between presence of psoriatic arthritis and plasma VEGF level (mean relapse VEGFarthritis = 277 pg/mL; mean relapse VEGFnonarthritis = 103.5 pg/mL; P = .03).

Conclusions  Generalized pustular psoriasis is accompanied by pathological proteinuria and elevated plasma VEGF levels. Plasma VEGF concentration is significantly elevated in patients with extensive skin and joint involvement and may act on renal microvasculature to induce hyperpermeability.


From St John's Institute of Dermatology, St Thomas' Hospital, King's College Hospital, London, England (Drs Creamer and Barker and Mr Allen); the Molecular Angiogenesis Group, Imperial Cancer Research Fund, Institute of Molecular Medicine, Oxford, England (Drs Jaggar and Bicknell); and the Department of Rheumatology, St Thomas' Hospital, London (Dr Stevens).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psoriasis: advances in pathophysiology and management
MacDonald and Burden
Postgrad. Med. J. 2007;83:690-697.
ABSTRACT | FULL TEXT  

Annual Trainee Award, 2001-2002
Orlow
Arch Dermatol 2003;139:378-378.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.